Skip to main content

Advertisement

SpringerLink
Log in

Features, Predictors, and Treatment of Breast Cancer–Related Lymphedema

  • Lymphedema Incidence, Prevention and Treatment (J Armer, Section Editor)
  • Published:
Current Breast Cancer Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Breast cancer–related lymphedema (BCRL) is a common sequelae among breast cancer survivors. This review provides updated information on recent studies to prevent, diagnose, and actively treat women with BCRL.

Recent Findings

In total, 63 articles were identified from 2015 and 2020 that assessed incidence, risk factors, surveillance, measurement and definition, treatment, and awareness of BCRL. Depending on the approach and timing of assessment, BCRL incidence rates ranged from 9.1 to 39%. Modified radical mastectomy, number of positive lymph nodes, and postoperative complications were linked to BCRL risk, in addition to chemotherapy, radiation, axillary lymph node dissection, advanced cancer stage, and higher body mass index. Early detection showed favorable BCRL outcomes (e.g., severity, symptoms). Exercise, self-management, complete decongestive therapy, bandaging, and surgery had positive effects on BCRL outcomes.

Summary

Numerous gaps exist within BCRL literature, such as the value of self-reported surveillance options to identify BCRL early, measurement strategies, and definitions of BCRL. In terms of policies, efforts are needed to educate providers, patients, payers, and legislators about the need for consensus to reduce the burden of BCRL in women being treated for breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.

    Article  Google Scholar 

  2. Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–85.

    PubMed  Google Scholar 

  3. Lawenda BD, Mondry TE, Johnstone PA. Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. CA Cancer J Clin. 2009;59(1):8–24.

    PubMed  Google Scholar 

  4. McLaughlin SA, Bagaria S, Gibson T, Arnold M, Diehl N, Crook J, et al. Trends in risk reduction practices for the prevention of lymphedema in the first 12 months after breast cancer surgery. J Am Coll Surg. 2013;216(3):380–9.

    PubMed  Google Scholar 

  5. Basta MN, Wu LC, Kanchwala SK, Serletti JM, Tchou JC, Kovach SJ, et al. Reliable prediction of postmastectomy lymphedema: the Risk Assessment Tool Evaluating Lymphedema. Am J Surg. 2017;213(6):1125–33 e1.

    PubMed  Google Scholar 

  6. Kaufman DI, Shah C, Vicini FA, Rizzi M. Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema. Breast Cancer Res Treat. 2017;166(3):809–15.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Kilgore LJ, Korentager SS, Hangge AN, Amin AL, Balanoff CR, Larson KE, et al. Reducing breast cancer-related lymphedema (BCRL) through prospective surveillance monitoring using bioimpedance spectroscopy (BIS) and patient directed self-interventions. Ann Surg Oncol. 2018;25(10):2948–52.

    PubMed  Google Scholar 

  8. Koelmeyer LA, Borotkanics RJ, Alcorso J, Prah P, Winch CJ, Nakhel K, et al. Early surveillance is associated with less incidence and severity of breast cancer-related lymphedema compared with a traditional referral model of care. Cancer. 2019;125(6):854–62.

    PubMed  Google Scholar 

  9. Laidley A, Anglin B. The impact of L-Dex((R)) measurements in assessing breast cancer-related lymphedema as part of routine clinical practice. Front Oncol. 2016;6:192.

    PubMed  PubMed Central  Google Scholar 

  10. Nguyen TT, Hoskin TL, Habermann EB, Cheville AL, Boughey JC. Breast cancer-related lymphedema risk is related to multidisciplinary treatment and not surgery alone: results from a large cohort study. Ann Surg Oncol. 2017;24(10):2972–80.

    PubMed  PubMed Central  Google Scholar 

  11. Park JH. The effects of complex exercise on shoulder range of motion and pain for women with breast cancer-related lymphedema: a single-blind, randomized controlled trial. Breast Cancer. 2017;24(4):608–14.

    PubMed  Google Scholar 

  12. Penha TR, Botter B, Heuts EM, Voogd AC, von Meyenfeldt MF, van der Hulst RR. Quality of life in patients with breast cancer-related lymphedema and reconstructive breast surgery. J Reconstr Microsurg. 2016;32(6):484–90.

    PubMed  Google Scholar 

  13. Rupp J, Hadamitzky C, Henkenberens C, Christiansen H, Steinmann D, Bruns F. Frequency and risk factors for arm lymphedema after multimodal breast-conserving treatment of nodal positive breast cancer - a long-term observation. Radiat Oncol. 2019;14(1):39.

    PubMed  PubMed Central  Google Scholar 

  14. Zou L, Liu FH, Shen PP, Hu Y, Liu XQ, Xu YY, et al. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study. Breast Cancer. 2018;25(3):309–14.

    PubMed  Google Scholar 

  15. Chowdhry M, Rozen WM, Griffiths M. Lymphatic mapping and preoperative imaging in the management of post-mastectomy lymphoedema. Gland surgery. 2016;5(2):187–96.

    PubMed  PubMed Central  Google Scholar 

  16. Hespe GE, Nitti MD, Mehrara BJ. Pathophysiology of lymphedema. Lymphedema: Springer; 2015. p. 9–18.

  17. Rusznyák I, Földi M, Szabó G. Lymphatics and lymph circulation: physiology and pathology: Elsevier; 2013.

  18. Shih Y-CT XY, Cormier JN, Giordano S, Ridner SH, Buchholz TA, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009;27(12):2007–14.

    Google Scholar 

  19. Paskett ED, Dean JA, Oliveri JM, Harrop JP. Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review. J Clin Oncol. 2012;30(30):3726–33.

    PubMed  Google Scholar 

  20. Ahmed RL, Prizment A, Lazovich D, Schmitz KH, Folsom AR. Lymphedema and quality of life in breast cancer survivors: the Iowa Women’s Health Study. J Clin Oncol. 2008;26(35):5689–96.

    PubMed  PubMed Central  Google Scholar 

  21. Albright HW, Moreno M, Feeley TW, Walters R, Samuels M, Pereira A, et al. The implications of the 2010 patient protection and affordable care act and the health care and education reconciliation act on cancer care delivery. Cancer. 2011;117(8):1564–74.

    PubMed  Google Scholar 

  22. Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77(2):109–30.

    PubMed  Google Scholar 

  23. Lam R, Wallace A, Burbidge B, Franks P, Moffatt C. Experiences of patients with lymphoedema. J Lymphoedema. 2006;1(1):16–21.

    Google Scholar 

  24. Paskett E BS, Khakpour N, O’Connor T, Silverman P. . Lymphedema. In: NCCN clinical practice guidelines in oncology (NCCN guidelines): Survivorship. Version 2.2019 ed: National Comprehensive Cancer Network; 2019.

  25. Park S, Lee JE, Yu J, Paik HJ, Ryu JM, Kim I, et al. Risk factors affecting breast cancer-related lymphedema: serial body weight change during neoadjuvant anthracycline plus cyclophosphamide followed by taxane. Clin Breast Cancer. 2018;18(1):e49–54.

    CAS  PubMed  Google Scholar 

  26. Vicini F, Shah C, Whitworth P, Walker M, Shi J. Correlation of bioimpedance spectroscopy with risk factors for the development of breast cancer-related lymphedema. Lymphat Res Biol. 2018.

  27. Dean LT, Kumar A, Kim T, Herling M, Brown JC, Zhang Z, et al. Race or resource? BMI, race, and other social factors as risk factors for interlimb differences among overweight breast cancer survivors with lymphedema. J Obes. 2016;2016:8241710.

    PubMed  PubMed Central  Google Scholar 

  28. Eyigor S, Cinar E, Caramat I, Unlu BK. Factors influencing response to lymphedema treatment in patients with breast cancer-related lymphedema. Support Care Cancer. 2015;23(9):2705–10.

    PubMed  Google Scholar 

  29. Yoon JA, Shin YB, Shin MJ, Yun RY, Kim KY, Song YS, et al. An assessment of the relationship between abdominal obesity and the severity of upper extremity lymphedema. Lymphat Res Biol. 2018;16(5):458–63.

    PubMed  Google Scholar 

  30. Coriddi M, Khansa I, Stephens J, Miller M, Boehmler J, Tiwari P. Analysis of factors contributing to severity of breast cancer-related lymphedema. Ann Plast Surg. 2015;74(1):22–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Penn IW, Chang YC, Chuang E, Chen CM, Chung CF, Kuo CY, et al. Risk factors and prediction model for persistent breast-cancer-related lymphedema: a 5-year cohort study. Support Care Cancer. 2019;27(3):991–1000.

    PubMed  Google Scholar 

  32. Sherman KA, Kilby CJ, Elder E, Ridner SH. Factors associated with professional healthcare advice seeking in women at risk for developing breast cancer-related lymphedema. Patient Educ Couns. 2018;101(3):445–51.

    PubMed  Google Scholar 

  33. Alcorso J, Sherman KA, Koelmeyer L, Mackie H, Boyages J. Psychosocial factors associated with adherence for self-management behaviors in women with breast cancer-related lymphedema. Support Care Cancer. 2016;24(1):139–46.

    PubMed  Google Scholar 

  34. Lee D, Hwang JH, Chu I, Chang HJ, Shim YH, Kim JH. Analysis of factors related to arm weakness in patients with breast cancer-related lymphedema. Support Care Cancer. 2015;23(8):2297–304.

    PubMed  Google Scholar 

  35. O’Toole JA, Ferguson CM, Swaroop MN, Horick N, Skolny MN, Brunelle CL, et al. The impact of breast cancer-related lymphedema on the ability to perform upper extremity activities of daily living. Breast Cancer Res Treat. 2015;150(2):381–8.

    PubMed  Google Scholar 

  36. Ridner SH, Dietrich MS, Cowher MS, Taback B, McLaughlin S, Ajkay N, et al. A randomized trial evaluating bioimpedance spectroscopy versus tape measurement for the prevention of lymphedema following treatment for breast cancer: interim analysis. Ann Surg Oncol. 2019;26(10):3250–9.

    PubMed  PubMed Central  Google Scholar 

  37. Whitworth PW, Shah C, Vicini F, Cooper A. Preventing breast cancer-related lymphedema in high-risk patients: the impact of a structured surveillance protocol using bioimpedance spectroscopy. Front Oncol. 2018;8:197.

    PubMed  PubMed Central  Google Scholar 

  38. Buchan J, Janda M, Box R, Schmitz K, Hayes S. A randomized trial on the effect of exercise mode on breast cancer-related lymphedema. Med Sci Sports Exerc. 2016;48(10):1866–74.

    CAS  PubMed  Google Scholar 

  39. Brown JC, Kumar A, Cheville AL, Tchou JC, Troxel AB, Harris SR, et al. Association between lymphedema self-care adherence and lymphedema outcomes among women with breast cancer-related lymphedema. Am J Phys Med Rehabil. 2015;94(4):288–96.

    PubMed  PubMed Central  Google Scholar 

  40. Singh B, Buchan J, Box R, Janda M, Peake J, Purcell A, et al. Compression use during an exercise intervention and associated changes in breast cancer-related lymphedema. Asia Pac J Clin Oncol. 2016;12(3):216–24.

    PubMed  Google Scholar 

  41. Lin CY, Liu HE, Cheng MH. Factors associated with professional healthcare advice seeking in breast cancer-related lymphedema. J Surg Oncol. 2020;121(1):67–74.

    PubMed  Google Scholar 

  42. Simonavice E, Kim JS, Panton L. Effects of resistance exercise in women with or at risk for breast cancer-related lymphedema. Support Care Cancer. 2017;25(1):9–15.

    PubMed  Google Scholar 

  43. Czerniec SA, Ward LC, Kilbreath SL. Breast cancer-related arm lymphedema: fluctuation over six months and the effect of the weather. Lymphat Res Biol. 2016;14(3):148–55.

    PubMed  Google Scholar 

  44. Cornish B, Chapman M, Hirst C, Mirolo B, Bunce I, Ward L, et al. Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology. 2001;34(1):2–11.

    CAS  PubMed  Google Scholar 

  45. Ergin G, Sahinoglu E, Karadibak D, Yavuzsen T. Effectiveness of Kinesio Taping on anastomotic regions in patients with breast cancer-related lymphedema: a randomized controlled pilot study. Lymphat Res Biol. 2019;17(6):655–60.

    PubMed  Google Scholar 

  46. Mazor M, Lee JQ, Peled A, Zerzan S, Irwin C, Chesney MA, et al. The effect of yoga on arm volume, strength, and range of motion in women at risk for breast cancer-related lymphedema. J Altern Complement Med. 2018;24(2):154–60.

    PubMed  Google Scholar 

  47. Ochalek K, Gradalski T, Partsch H. Preventing early postoperative arm swelling and lymphedema manifestation by compression sleeves after axillary lymph node interventions in breast cancer patients: a randomized controlled trial. J Pain Symptom Manag. 2017;54(3):346–54.

    Google Scholar 

  48. Omar MTA, Gwada RFM, Omar GSM, El-Sabagh RM, Mersal AAE. Low-intensity resistance training and compression garment in the management of breast cancer-related lymphedema: single-blinded randomized controlled trial. J Cancer Educ 2019.

  49. Vignes S, Fau-Prudhomot P, Simon L, Sanchez-Brechot ML, Arrault M, Locher F. Impact of breast cancer-related lymphedema on working women. Support Care Cancer. 2020;28(1):79–85.

    PubMed  Google Scholar 

  50. Duyur Cakit B, Pervane Vural S, Ayhan FF. Complex decongestive therapy in breast cancer-related lymphedema: does obesity affect the outcome negatively? Lymphat Res Biol. 2019;17(1):45–50.

    CAS  PubMed  Google Scholar 

  51. Dean LT, Moss SL, Ransome Y, Frasso-Jaramillo L, Zhang Y, Visvanathan K, et al. “It still affects our economic situation”: long-term economic burden of breast cancer and lymphedema. Support Care Cancer. 2019;27(5):1697–708.

    PubMed  Google Scholar 

  52. Sitzia J. Volume measurement in lymphoedema treatment: examination of formulae. Eur J Cancer Care. 1995;4(1):11–6.

    CAS  Google Scholar 

  53. Yamamoto T, Yamamoto N, Hara H, Mihara M, Narushima M, Koshima I. Upper extremity lymphedema index: a simple method for severity evaluation of upper extremity lymphedema. Ann Plast Surg. 2013;70(1):47–9.

    CAS  PubMed  Google Scholar 

  54. Wolfs J, de Joode L, van der Hulst R, Qiu SS. Correlation between patency and clinical improvement after lymphaticovenous anastomosis (LVA) in breast cancer-related lymphedema: 12-month follow-up. Breast Cancer Res Treat. 2020;179(1):131–8.

    PubMed  Google Scholar 

  55. Ligabue MB, Campanini I, Veroni P, Cepelli A, Lusuardi M, Merlo A. Efficacy of self-administered complex decongestive therapy on breast cancer-related lymphedema: a single-blind randomized controlled trial. Breast Cancer Res Treat. 2019;175(1):191–201.

    CAS  PubMed  Google Scholar 

  56. Zhang X, Brown JC, Paskett ED, Zemel BS, Cheville AL, Schmitz KH. Changes in arm tissue composition with slowly progressive weight-lifting among women with breast cancer-related lymphedema. Breast Cancer Res Treat. 2017;164(1):79–88.

    PubMed  PubMed Central  Google Scholar 

  57. Arinaga Y, Sato F, Piller N, Kakamu T, Kikuchi K, Ohtake T, et al. A 10 minute self-care program may reduce breast cancer-related lymphedema: a six-month prospective longitudinal comparative study. Lymphology. 2016;49(2):93–106.

    CAS  PubMed  Google Scholar 

  58. Fu MR, Axelrod D, Cleland CM, Qiu Z, Guth AA, Kleinman R, et al. Symptom report in detecting breast cancer-related lymphedema. Breast Cancer (Dove Med Press). 2015;7:345–52.

    Google Scholar 

  59. Spinelli B, Kallan MJ, Zhang X, Cheville A, Troxel A, Cohn J, et al. Intra-and interrater reliability and concurrent validity of a new tool for assessment of breast cancer–related lymphedema of the upper extremity. Arch Phys Med Rehabil. 2019;100(2):315–26.

    PubMed  Google Scholar 

  60. Rafn BS, McNeely ML, Camp PG, Midtgaard J, Campbell KL. Self-measured arm circumference in women with breast cancer is reliable and valid. Phys Ther. 2019;99(2):240–53.

    PubMed  Google Scholar 

  61. Norkin CC, White DJ. Measurement of joint motion: a guide to goniometry: FA Davis; 2016.

  62. Sanal-Toprak C, Ozsoy-Unubol T, Bahar-Ozdemir Y, Akyuz G. The efficacy of intermittent pneumatic compression as a substitute for manual lymphatic drainage in complete decongestive therapy in the treatment of breast cancer related lymphedema. Lymphology. 2019;52(2):82–91.

    CAS  PubMed  Google Scholar 

  63. Jang DH, Kim MW, Oh SJ, Kim JM. The influence of arm swelling duration on shoulder pathology in breast cancer patients with lymphedema. PLoS One. 2015;10(11):e0142950.

    PubMed  PubMed Central  Google Scholar 

  64. Temur K, Kapucu S. The effectiveness of lymphedema self-management in the prevention of breast cancer-related lymphedema and quality of life: a randomized controlled trial. Eur J Oncol Nurs. 2019;40:22–35.

    PubMed  Google Scholar 

  65. Donmez AA, Kapucu S. The effectiveness of a clinical and home-based physical activity program and simple lymphatic drainage in the prevention of breast cancer-related lymphedema: a prospective randomized controlled study. Eur J Oncol Nurs. 2017;31:12–21.

    PubMed  Google Scholar 

  66. Beaton DE, Katz JN, Fossel AH, Wright JG, Tarasuk V, Bombardier C. Measuring the whole or the parts?: validity, reliability, and responsiveness of the Disabilities of the Arm, Shoulder and Hand outcome measure in different regions of the upper extremity. J Hand Ther. 2001;14(2):128–42.

    CAS  PubMed  Google Scholar 

  67. Ridner SH, Dietrich MS, Davis AJ, Sinclair V. A randomized clinical trial comparing the impact of a web-based multimedia intervention versus an educational pamphlet on patient outcomes in breast cancer survivors with chronic secondary lymphedema. J Women's Health (Larchmt). 2020;29(5):734–44.

    Google Scholar 

  68. Norman SA, Localio AR, Kallan MJ, Weber AL, Torpey HAS, Potashnik SL, et al. Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol Prev Biomarkers. 2010;19(11):2734–46.

    Google Scholar 

  69. Isl I. The diagnosis and treatment of peripheral lymphedema 2009 consensus document of the International Society of Lymphology. Lymphology. 2009;42(2):51–60.

    Google Scholar 

  70. Borman P, Yaman A, Yasrebi S, Ozdemir O. The importance of awareness and education in patients with breast cancer-related lymphedema. J Cancer Educ. 2017;32(3):629–33.

    PubMed  Google Scholar 

  71. Schmitz KH, Troxel AB, Dean LT, DeMichele A, Brown JC, Sturgeon K, et al. Effect of home-based exercise and weight loss programs on breast cancer-related lymphedema outcomes among overweight breast cancer survivors: the WISER Survivor Randomized Clinical Trial. JAMA Oncol. 2019;5:1605.

    PubMed Central  Google Scholar 

  72. Mobarakeh ZS, Mokhtari-Hesari P, Lotfi-Tokaldany M, Montazeri A, Heidari M, Zekri F. Combined decongestive therapy and reduction of pain and heaviness in patients with breast cancer-related lymphedema. Support Care Cancer. 2019;27(10):3805–11.

    PubMed  Google Scholar 

  73. Pasyar N, Barshan Tashnizi N, Mansouri P, Tahmasebi S. Effect of yoga exercise on the quality of life and upper extremity volume among women with breast cancer related lymphedema: a pilot study. Eur J Oncol Nurs. 2019;42:103–9.

    PubMed  Google Scholar 

  74. Williams AE, Rapport F, Russell IT, Hutchings HA. Psychometric development of the Upper Limb Lymphedema Quality of Life Questionnaire demonstrated the patient-reported outcome measure to be a robust measure for breast cancer-related lymphedema. J Clin Epidemiol. 2018;100:61–70.

    PubMed  Google Scholar 

  75. De Vrieze T, Gebruers N, Nevelsteen I, Tjalma WAA, Thomis S, De Groef A, et al. Responsiveness of the Lymphedema Functioning, Disability, and Health Questionnaire for upper limb lymphedema in patients with breast cancer-related lymphedema. Lymphat Res Biol. 2020.

  76. Basta MN, Fox JP, Kanchwala SK, Wu LC, Serletti JM, Kovach SJ, et al. Complicated breast cancer-related lymphedema: evaluating health care resource utilization and associated costs of management. Am J Surg. 2016;211(1):133–41.

    PubMed  Google Scholar 

  77. Cheville A, Lee M, Moynihan T, Schmitz KH, Lynch M, De Choudens FR, et al. The impact of arm lymphedema on healthcare utilization during long-term breast cancer survivorship: a population-based cohort study. J Cancer Surviv. 2020:1–9.

  78. Mestre S, Calais C, Gaillard G, Nou M, Pasqualini M, Ben Amor C, et al. Interest of an auto-adjustable nighttime compression sleeve (MOBIDERM(R) Autofit) in maintenance phase of upper limb lymphedema: the MARILYN pilot RCT. Support Care Cancer. 2017;25(8):2455–62.

    CAS  PubMed  PubMed Central  Google Scholar 

  79. Oh SH, Ryu SH, Jeong HJ, Lee JH, Sim YJ. Effects of different bandaging methods for treating patients with breast cancer-related lymphedema. Ann Rehabil Med. 2019;43(6):677–85.

    PubMed  PubMed Central  Google Scholar 

  80. Ergin G, Sahinoglu E, Karadibak D, Yavuzsen T. Effect of bandage compliance on upper extremity volume in patients with breast cancer-related lymphedema. Lymphat Res Biol. 2018;16(6):553–8.

    PubMed  Google Scholar 

  81. Ngo QD, Munot S, Mackie H, Czerniec S, Koelmeyer LA, Lam T, et al. Vascularized lymph node transfer for patients with breast cancer-related lymphedema can potentially reduce the burden of ongoing conservative management. Lymphat Res Biol. 2020.

  82. Chang EI, Ibrahim A, Liu J, Robe C, Suami H, Hanasono MM, et al. Optimizing quality of life for patients with breast cancer related lymphedema: a prospective study combining DIEP flap breast reconstruction and lymphedema surgery. Plast Reconstr Surg. 2020;145:676e–85e.

    CAS  PubMed  Google Scholar 

Download references

Funding

This study is funded by an award from The Breast Cancer Research Foundation.

Author information

Authors and Affiliations

  1. Division of Population Sciences, Comprehensive Cancer Center, The Ohio State University, 1590 N High Street, Suite 525, Columbus, OH, USA

    Xiaochen Zhang, Jill M. Oliveri & Electra D. Paskett

Authors
  1. Xiaochen Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jill M. Oliveri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Electra D. Paskett
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Electra D. Paskett.

Ethics declarations

Conflict of Interest

Electra Paskett reports grants from Breast Cancer Research Foundation, grants from NIH, during the conduct of the study; grants from Merck Foundation, grants from Pfizer, grants from Komen Columbus Foundation, grants from Ohio Department of Health, other from FoxConn, grants from Social Impact Fund, grants from Komen Foundation, and grants from PICORI, outside the submitted work.

Jill Oliveri and Xiaochen Zhang declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Lymphedema Incidence, Prevention and Treatment

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, X., Oliveri, J.M. & Paskett, E.D. Features, Predictors, and Treatment of Breast Cancer–Related Lymphedema. Curr Breast Cancer Rep 12, 244–254 (2020). https://doi.org/10.1007/s12609-020-00381-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12609-020-00381-0

Keywords

Search

Navigation